Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
$0.81
+0.8%
$0.77
$0.57
$3.04
$83.46M0.1861,056 shs18,792 shs
Doma Holdings Inc. stock logo
DOMA
Doma
$6.02
-0.5%
$5.33
$3.86
$11.08
$83.61M1.5738,052 shs11,829 shs
Red Cat Holdings, Inc. stock logo
RCAT
Red Cat
$1.19
+5.3%
$0.94
$0.53
$1.65
$88.40MN/A522,093 shs1.14 million shs
Zenvia Inc. stock logo
ZENV
Zenvia
$2.07
+1.5%
$2.18
$0.65
$2.97
$86.40M1.97159,125 shs42,757 shs
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
0.00%-5.06%+13.66%-2.77%-72.55%
Doma Holdings Inc. stock logo
DOMA
Doma
0.00%0.00%-0.33%+53.55%-41.32%
Red Cat Holdings, Inc. stock logo
RCAT
Red Cat
0.00%-18.71%+44.69%+87.71%+28.66%
Zenvia Inc. stock logo
ZENV
Zenvia
0.00%-10.13%-6.42%+77.39%+155.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/AN/AN/AN/A
Doma Holdings Inc. stock logo
DOMA
Doma
2.7315 of 5 stars
3.35.00.00.02.42.50.0
Red Cat Holdings, Inc. stock logo
RCAT
Red Cat
N/AN/AN/AN/AN/AN/AN/AN/A
Zenvia Inc. stock logo
ZENV
Zenvia
2.1857 of 5 stars
0.05.00.00.02.72.51.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/A
Doma Holdings Inc. stock logo
DOMA
Doma
2.50
Moderate Buy$13.15118.36% Upside
Red Cat Holdings, Inc. stock logo
RCAT
Red Cat
N/AN/AN/AN/A
Zenvia Inc. stock logo
ZENV
Zenvia
N/AN/AN/AN/A

Current Analyst Ratings

Latest BNR, RCAT, ZENV, and DOMA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/15/2024
Doma Holdings Inc. stock logo
DOMA
Doma
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Outperform$20.00
4/2/2024
Doma Holdings Inc. stock logo
DOMA
Doma
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$6.00 ➝ $6.29
3/14/2024
Doma Holdings Inc. stock logo
DOMA
Doma
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetMarket Outperform ➝ Market Outperform$25.00 ➝ $20.00
(Data available from 5/6/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
$75.70M1.10N/AN/A$1.05 per share0.77
Doma Holdings Inc. stock logo
DOMA
Doma
$310.94M0.27N/AN/A($1.92) per share-3.14
Red Cat Holdings, Inc. stock logo
RCAT
Red Cat
$17.90M4.94N/AN/A$1.00 per share1.19
Zenvia Inc. stock logo
ZENV
Zenvia
$765.45M0.11N/AN/A$4.42 per share0.47

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
-$92.07M-$0.89N/AN/A-121.79%-71.77%-52.80%6/4/2024 (Estimated)
Doma Holdings Inc. stock logo
DOMA
Doma
-$124.41M-$9.39N/AN/A-38.39%-2,120.08%-38.05%5/14/2024 (Estimated)
Red Cat Holdings, Inc. stock logo
RCAT
Red Cat
-$27.09M-$0.52N/AN/A-206.42%-52.40%-47.59%7/25/2024 (Estimated)
Zenvia Inc. stock logo
ZENV
Zenvia
-$47.07M-$0.89N/A69.00N/A-24.29%-19.74%-9.94%5/15/2024 (Estimated)

Latest BNR, RCAT, ZENV, and DOMA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/28/2024Q4 2023
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/A-$0.22-$0.22-$0.22N/A$17.05 million
3/18/2024Q3 2024
Red Cat Holdings, Inc. stock logo
RCAT
Red Cat
N/A-$0.04-$0.04-$0.06N/A$5.85 million    
3/12/2024Q4 2023
Doma Holdings Inc. stock logo
DOMA
Doma
N/A-$1.22-$1.22-$0.90N/A$84.61 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/A
Doma Holdings Inc. stock logo
DOMA
Doma
N/AN/AN/AN/AN/A
Red Cat Holdings, Inc. stock logo
RCAT
Red Cat
N/AN/AN/AN/AN/A
Zenvia Inc. stock logo
ZENV
Zenvia
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/A
3.36
3.09
Doma Holdings Inc. stock logo
DOMA
Doma
N/A
1.05
1.05
Red Cat Holdings, Inc. stock logo
RCAT
Red Cat
N/A
5.34
3.61
Zenvia Inc. stock logo
ZENV
Zenvia
0.02
0.53
0.53

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
30.03%
Doma Holdings Inc. stock logo
DOMA
Doma
20.67%
Red Cat Holdings, Inc. stock logo
RCAT
Red Cat
37.97%
Zenvia Inc. stock logo
ZENV
Zenvia
49.25%

Insider Ownership

CompanyInsider Ownership
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
30.30%
Doma Holdings Inc. stock logo
DOMA
Doma
29.50%
Red Cat Holdings, Inc. stock logo
RCAT
Red Cat
30.50%
Zenvia Inc. stock logo
ZENV
Zenvia
78.37%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
1,138102.64 million71.54 millionNot Optionable
Doma Holdings Inc. stock logo
DOMA
Doma
23913.89 million9.79 millionOptionable
Red Cat Holdings, Inc. stock logo
RCAT
Red Cat
7674.28 million51.11 millionOptionable
Zenvia Inc. stock logo
ZENV
Zenvia
1,19141.74 million9.03 millionNot Optionable

BNR, RCAT, ZENV, and DOMA Headlines

SourceHeadline
3 Little-Known Stocks That Could Make You Rich by 20293 Little-Known Stocks That Could Make You Rich by 2029
investorplace.com - May 3 at 7:00 AM
Heres what to expect from Zenvia As earningsHere's what to expect from Zenvia A's earnings
markets.businessinsider.com - April 30 at 8:22 PM
38% of Zenvia Inc. (NASDAQ:ZENV) is owned by insiders, and theyve been buying recently38% of Zenvia Inc. (NASDAQ:ZENV) is owned by insiders, and they've been buying recently
finance.yahoo.com - April 28 at 2:00 PM
Zenvia Inc. (NASDAQ:ZENV) Sees Large Decline in Short InterestZenvia Inc. (NASDAQ:ZENV) Sees Large Decline in Short Interest
americanbankingnews.com - April 27 at 3:40 AM
Hidden Titans: 3 Stocks Ready to Outperform in the Next Earnings SeasonHidden Titans: 3 Stocks Ready to Outperform in the Next Earnings Season
investorplace.com - April 20 at 6:00 AM
ZENVIA sets agenda for fiscal fourth quarter and full year resultsZENVIA sets agenda for fiscal fourth quarter and full year results
prnewswire.com - April 15 at 8:50 AM
Zenvia (NASDAQ:ZENV) Trading 1.8% Higher Zenvia (NASDAQ:ZENV) Trading 1.8% Higher
marketbeat.com - April 10 at 2:18 AM
Secret Millionaires: 3 Underpriced Stocks to Skyrocket Your WealthSecret Millionaires: 3 Underpriced Stocks to Skyrocket Your Wealth
investorplace.com - April 9 at 8:00 AM
Zenvia: The Brazilian UnderdogZenvia: The Brazilian Underdog
seekingalpha.com - April 9 at 3:02 AM
Millionaire Blueprint: 3 Game-Changing Stocks You Cant IgnoreMillionaire Blueprint: 3 Game-Changing Stocks You Can't Ignore
investorplace.com - April 4 at 8:38 AM
Zenvia Up 24%, Insider Buyers Are Up 133%Zenvia Up 24%, Insider Buyers Are Up 133%
finance.yahoo.com - April 1 at 4:58 PM
Darwin AI gives small LatAm companies AI-powered sales assistantDarwin AI gives small LatAm companies AI-powered sales assistant
techcrunch.com - February 26 at 9:36 AM
OGEN, SSP and ZENV among mid-day moversOGEN, SSP and ZENV among mid-day movers
seekingalpha.com - February 7 at 2:44 PM
Runners raising money for Marathon KidsRunners raising money for Marathon Kids
msn.com - February 6 at 1:13 PM
Zenvia Shares Touch 52-Week High After Funding ImprovementZenvia Shares Touch 52-Week High After Funding Improvement
marketwatch.com - February 6 at 1:13 PM
Zenvia Announces Agreements to Address Funding Gap and Introduces EBITDA Guidance for 2024Zenvia Announces Agreements to Address Funding Gap and Introduces EBITDA Guidance for 2024
finance.yahoo.com - February 6 at 1:13 PM
A2p Sms Messaging Market Booming With Top Key Players Executing Different Strategies And PlansA2p Sms Messaging Market Booming With Top Key Players Executing Different Strategies And Plans
opprairie.com - February 6 at 7:30 AM
Zenvia Inc - (ZENV) Price Target Increased by 5.68% to 1.58Zenvia Inc - (ZENV) Price Target Increased by 5.68% to 1.58
msn.com - November 27 at 7:59 AM
Zenvia Inc. (NASDAQ:ZENV) Q3 2023 Earnings Call TranscriptZenvia Inc. (NASDAQ:ZENV) Q3 2023 Earnings Call Transcript
finance.yahoo.com - November 20 at 3:47 PM
OPTX, EXFY among major tech gainers; TRT, ATGL among losersOPTX, EXFY among major tech gainers; TRT, ATGL among losers
msn.com - November 18 at 1:15 AM
Crude Oil Rises Over 3%; BJs Wholesale Posts Weak SalesCrude Oil Rises Over 3%; BJ's Wholesale Posts Weak Sales
markets.businessinsider.com - November 17 at 3:14 PM
Zenvia: ZENVIA Reports Q3 2023 and 9M 2023 ResultsZenvia: ZENVIA Reports Q3 2023 and 9M 2023 Results
finanznachrichten.de - November 17 at 9:56 AM
Zenvia reports Q3 resultsZenvia reports Q3 results
msn.com - November 16 at 8:58 PM
ZENVIA Reports Q3 2023 and 9M 2023 ResultsZENVIA Reports Q3 2023 and 9M 2023 Results
finance.yahoo.com - November 16 at 8:58 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Burning Rock Biotech logo

Burning Rock Biotech

NASDAQ:BNR
Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.
Doma logo

Doma

NYSE:DOMA
Doma Holdings Inc. issues residential and commercial title insurance for purchase and refinance transactions in the United States. It operates through two segments, Underwriting; and Corporate and Other. The company offers title insurance underwriting, including policies referred to through its third-party agents' channel; and other insurance services for the residential real estate market. It also provides title, escrow, and settlement services for residential refinance transactions through its direct agents; and is involved in investing activities for its investment portfolio. The company serves homeowners, lenders, title agents, and real estate professionals. Doma Holdings Inc. was founded in 2016 and is headquartered in San Francisco, California.
Red Cat logo

Red Cat

NASDAQ:RCAT
Red Cat Holdings, Inc. engages in the provision of various products, services, and solutions to the drone industry. The company operates through two segments: Enterprise and Consumer. It built infrastructure to manages drone fleets and fly, and provide services remotely, navigate confined industrial interior spaces and dangerous military environment. Red Cat Holdings, Inc. is based in San Juan, Puerto Rico.
Zenvia logo

Zenvia

NASDAQ:ZENV
Zenvia Inc. provides customer experience communications platform which empowers businesses to create unique journeys for their end-customers along their life cycle across range of B2C verticals. Zenvia Inc. is based in S?O PAULO.